(Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced that its Board of Directors has authorized an amended Stock Repurchase ...

I’m just really glad that the people of South Bank have put their trust in me again and I hope I’ll do a good job for them' ...

In March 2014, Anaptys entered into the Collaboration Agreement ith Tesaro, an oncology-focused biopharmaceutical company now a part of GSK. Currently, under the Collaboration Agreement, Tesaro is ...